Self-assembled surfactant nano-structures important in drug delivery: A review

Indian Journal of Experimental Biology

Volumn 45, Issue 2, 2007, Pages 133-159

  Sagar, Giddi Hema ^a   Arunagirinathan, M A ^a   Bellare, Jayesh R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Drug delivery; Self assembled surfactant nano structure

Indexed keywords

LIPOSOME; NANOMATERIAL; PHOSPHOLIPID; SURFACTANT;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; MICELLE; PH; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICELLES; NANOSTRUCTURES; PHOSPHOLIPIDS; SURFACE-ACTIVE AGENTS;

EID: 34047247870     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. Juliano R L, Drug delivery systems: characteristics and biomedical applications (New York Oxford University Press) 1980.
2. Tejwani Saurabh & Bellare Jayesh R., Nanotechnology in bioengineering, Chapter 2 in "Advances in nanoscience and nanotechnology" edited by Ashutosh Sharma, Jayesh Bellare, & Archana Sharma (National Institute of Science Communication And Information Resources, CSIR, New Delhi) 2004.
3. Lawrence M J, Surfactant systems: Their use in drug delivery, Chem Soc Rev, 23 (1994) 417.
4. Raymond S Tu & Matthew T, Bottom-up design of biomimetic assemblies, Adv Drug Rev, 56 (2004) 1537.
5. Drummond C J & Fong C, Surfactant self assembly objects as novel delivery vehicles, Current opinion in Colloid & Interface Science, 4 (2000) 449.
6. Kozubek A, Gubernator J, Przeworska E & Stasiuk M, Liposomal drug delivery, a novel approach PLARosomes, Acta Biochim Polon, 47 (2000) 639.
7. Kinam park, Controlled drug delivery : challenges and strategies (American Chemical Society Washington, DC) 1997.
8. Swisher R D, Surfactant biodegradation (Marcel Dekker Inc New York) 1987.
9. Cain R B, Biodegradation of detergents, Curr Opin Biotechnol, 5 (1994) 266.
10. Israelachvili J, Intermolecular and Surface Forces, second edition (Academic Press London) 1991.
11. Nagranjan R, Molecular packing parameter and surfactant self assembly: The neglected role of the surfactant tail, Langmuir, 18 (2002) 31.
12. Kumare V V, Complementary molecular shapes and additivity of the packing parameter of lipids, Proc Natl Acad Sci USA, 88 (1991) 444.
13. Holmberg Krister, Surfactants and polymers in aqueous solutions (John Wiley Chichester) 2003.
14. Dubois M, Lizunov V, Meister A, Gulik-krzywick T & Verbavatzo J M, Shape control through molecular segregation in giant surfactant aggregates, Proc Natl Acad Sci USA, 101 (2004) 15082.
15. Echlin P, Low-temperature microscopy and analysis (Plenum Press New York) 1992.
16. Hao Jingcheng & Hoffman H, Self assembled structures in excess and salt free catanionic surfactant solutions, Current Opinion in Colloid and Interface Science, 9 (2004) 279.
17. Almgren M, Edwards K & Karlsson G, Cryo-transmission electron microscopy of liposomes and related structures, Colloids and Surfaces A: Physicochem and Engearing Aspects, 174 (2000) 3.
18. Vinson P K, Bellare J R, Miller W G & Scriven L E, Direct imaging of surfactant micelles, vesicles, discs, and ripple phase structures by cryo-transmission electron microscopy, J colloid Interface Sci, 142 (1991) 74.
19. Karoon M, Wegdam G H & Sprik R, Dynamic light scattering studies on the sol-gel transition of a suspension of anisotropic colloidal particles, Phys Rev E, 54 (1996) 6541.
20. Zemb T & Charpin P, Micellar structure from comprasion of X-ray and neutron small angle scattering, J de Physique, 46 (1985) 249.
21. Bramer T, Paulson M, Edwards K & Edsman K, Catanionic Drug-Surfactant Mixtures: Phase Behavior and Sustained Release from Gels, Pharmaceutical Res, 20 (2003) 10.
22. Liu J &Lin Li, SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel, European J Pharmaceutical Sci, 25 (2005) 237.
23. Rodriguez R, Alvarez-Lorenzo C & Concheiro A, Influence of cationic cellulose structure on its interactions with sodium dodecylsulfate: implications on the properties of the aqueous dispersions and hydrogels, European J Pharmaceutics Biopharmaceutics, 56 (2003) 133.
24. Yamamoto K, Shah A C & Nishihata T, Enhanced rectal absorption of itazigrel formulated with polysorbate 80 micelle vehicle in rat: role of co-administered esterase, J Pharm Pharmacol, 46 (1994) 608.
25. Knemeyer I, Wientjes M G & Au J L, Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment, Cancer Chemotherapy Pharmacol, 44 (1999) 241.
26. Martin T J, Webber S E & Munk P, Onion-Type Micelles in Aqueous Media, Macromolecules, 29 (1996) 6526.
27. Erhardt R, Zhang M, Baker A, Zettl H, Abetz C, Frederick P, Krausch G, Abetz V & Miller A J E, Amphiphilic janus micelles with Polystyrene and Poly(methacrylicacid) Hemispheres, J Am Chem Soc, 125 ( 2003) 3260.
28. Stewart. S & Liu G J, Direct Polymer Intercalation in Single Crystal Vermiculite, Chem. Mater, 11 (1999) 1048.
29. Torchilin V P, Lipid-core micelles for targeted drug delivery, Curr Drug Deliv, 2 (2005) 319.
30. Liu J, Zeng F & Allen C, Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent, J Controlled Release, 103 (2005) 481.
31. Bhattarai N, Bhattarai S R, Yi H K, Lee J C, Khil M S, Hwang P H & Kim H Y, Novel polymeric micelles of amphiphilic triblock copolymer poly (p-dioxanone-co-Llactide)- block-poly (ethylene glycol), Pharm Res, 20 (2003) 2021.
32. Cho Y W, Lee J, Lee J C, Huh K M & Park K, Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles, J Controlled Release, 97 (2004) 249.
33. Ould-Ouali L, Noppe M, Langlois X, Williams B, Te Riele P, Timmerman P, Brewster M E, Arin A & Prat V, Selfassembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone, J Controlled Release, 102 (2005) 657.
34. Liaw J & Yen-Chao Lin, Evaluation of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) (PEO- PPO-PEO) gels as a release vehicle for percutaneous fentanyl, J Controlled Release, 68 (2000) 273.
35. Allena C, Hana C, Yua Y, Singer D M & Eisenberg A, Poly(caprolactone0-b-poly(ethylene oxide)copolymer micelles as a delivery vehicle for dihydrotestosterone, J Controlled Release, 63 (2000) 275.
36. Espuelas M S, Legrand P, Campanero M A, Appel M, Cheron M, Gamazo C, Barratt G & Irache J M, Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice, J Antimicrob Chemother, 52 (2003 ) 419.
37. Yu. B G, Okano T, Kataoka K, Sardari. S & Kwon G S, In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly (ethylene oxide)-block-poly(beta benzyl-L-aspartate) micelles, J Control Release, 4 (1998) 285.
38. Jian-Ping Xu, Jian Ji, Wei-Dong Chen & Jia-Cong Shen, Novel biomimetic polymersomes as polymer therapeutics for drug delivery, J Controlled Release, 107 (2005) 502.
39. Lee E S, Kun Na & Bae Y H, Doxorubicin loaded pHsensitive polymeric micelles for reversal of resistant MCF-7 tumor, J Controlled Release, 103 (2005) 405.
40. Hruby M, Konak C E & Ulbrich K, Polymeric micellar pHsensitive drug delivery system for doxorubicin, J Controlled Release, 103 (2005) 137.
41. Chau-Hui Wang, Chun-Hung Wang & Ging-Ho Hsiue, Polymeric micelles with a pH-responsive structure as intracellular drug carriers, J Controlled Release, 108 (2005) 140.
42. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M & Kataoka K, Preparation and biological characterization of polymeric micelle drug carriers with intracellular pHtriggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy, Bioconjug Chem, 16 (2005) 122.
43. Lukyanov A N, Gao Z, Mazzola L & Torchilin V P, Polyethylene Glycol-Diacyllipid Micelles Demonstrate Increased Accumulation in Subcutaneous Tumors in Mice, Pharma Res, 19 (2002) 1424.
44. Guo-Dong Zhang, Nishiyama N, Harada A, Dong-Lin Jiang, Aida T & Kataoka K, pH-sensitive Assembly of Light- Harvesting Dendrimer Zinc Porphyrin Bearing Peripheral Groups of Primary Amine with Poly(ethylene glycol)-bpoly( aspartic acid ) in Aqueous solution, Macromolecules, 36 (2003) 1304.
45. Lin W J, Juang L W & Lin C C, Stability and release performance of a series of pegylated co polymeric micelles, PharmRes, H 20 (2003) 668.
46. Jones M C, Ranger M & Leroux J C, pH-Sensitive Unimolecular Polymeric Micelles: Synthesis of a Novel Drug Carrier, Bioconjugate Chem, 14 (2003) 774.
47. Shim W S, Kim S W, Choi E K, Park H J, Kim J S, Lee D S, Novel pH sensitive block copolymer micelles for solvent free drug loading, Macromol Biosci, 3 (2006) 179.
48. Rapoport N, Marin A, Luo Y, Prestwich G D & Md. Muniruzzaman, Intracellular uptake and trafficking of pluronic micelles in drug-sensitive and MDR cells: Effect on the intracellular drug localization, J Pharmaceutical Sciences, 91 (2001) 157.
49. Garrec D L, Taillefer J, Van Lier J E, Lenaerts J & Leroux J C, Optimizing pH-responsive Polymeric Micelles for Drug Delivery in a Cancer Photodynamic Therapy Model, J Drug Targeting, 10 (2002) 429.
50. Kim Y, Dalhaimer P, Christian D A & Discher D E, Polymeric worm micelles as nano-carriers for drug delivery, Nanotechnology, 16 (2005) 484.
51. Croce V, Cosgrove T, Dreiss C A, Maitland G, Hughes T & Karlsson G, Impacting the length of wormlike micelles using mixed surfactant systems, Langmuir, 14 (2004) 7984.
52. Dalhaimer P, Engler A J, Parthasarathy R, Discher D E, Targeted worm micelles, Biomacromolecules, 5 (2004)1714.
53. Douliez J P, Navailles L & Nallet F, Self-assembly of fatty acid-alkylboladiamine salts, Langmuir, 22 (2006) 622.
54. Carlo S D, Fiaux H & Marca-Martinet C A, Electron Cryomicroscopy reveals mechanism of action of propranolol on artificial membranes, J Liposome Res, 14 (2004) 61.
55. Demana P H, Davies N M, Berger B & Rades T, Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method, Int J Pharmaceut, 278 (2004) 263.
56. Mats S, Karlsson G R & Edwards K, Vesicle Solubilization by Alkyl Sulfate Surfactants: A Cryo-TEM Study of the Vesicle to Micelle Transition, J Colloid and Interface Sci, 179 (1996) 104.
57. Johnsson M & Edwards K, Liposomes, Disks, and Spherical Micelles: Aggregate Structure in Mixtures of Gel Phase Phosphatidylcholines and Poly (Ethylene Glycol)- Phospholipids, Biophysical J, .85 (2003) 3839.
58. Vyas S P, Mysore N, Jaitely V & Venkatesan N, Discoidal niosome based controlled ocular delivery of timolol maleate, Pharmazie, 53 (1998) 466.
59. Ucbegbu I F, Bouwstra J A & Florence A T, Large Disk shaped structures (Discomes) in nonionic surfactant vesicle to micelle, J Phys Chem, 96 (1992) 10548.
60. Bangham A D, Liposomes : the Babraham Connection, Chem Phys Lipids, 64 (1993) 275.
61. Banerjee R & Jayesh R Bellare, In vitro evaluation of surfactants with eucalyptus oil for respiratory distress syndrome, Int J Aromatherap, 12 (2002) 40.
62. Banerjee R Jayesh R Bellare, Scoring of surface parameters of physiological relevance to exogenous surfactant therapy in respiratory distress syndrome (RDS), J Appl Physiol, 90 (2001) 1474.
63. Dhoot N O & Wheatley M A, Microencapsulated liposomes in controlled drug delivery: Strategies to modulate drug release and eliminate the burst effect, J Pharmaceutical Sci, 92 (2002) 679.
64. Bakker-Woudenberg A J M, Lokerse A F, Vinkvan den Berg J C & Roerdink F H, Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro, Infection, 16 (1988) S165.
65. Onyeji C O, Nightingale C H & Marangos M N, Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin, Infection, 22 (1994) 338.
66. Ran Y & Yalkowsky S H, Halothane, a Novel Solvent for the Preparation of Liposomes Containing 2-4'-Amino-3'- Methylphenyl Benzothiazole (AMPB), an Anticancer Drug: A Technical Note, AAPS Pharm Sci Tech, 4 (2003)1.
67. Esposito E, Menegatti E & Cortesi R, Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study, J Cosmet Sci., 55 (2004) 253.
68. Berrocal M C, Bujan J, Honduvilla J C & Abeger A, Comparison of the Effects of Dimyristoyl and Soya Phosphatidylcholine Liposomes on Human Fibroblasts, Drug Deliv 7 (2000) 37.
69. Soehngen E C, Godin-Ostro E, Fielder F G, Ginsberg R S, Slusher M A, & Weiner A L, Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats, Arthritis Rheum, 313 (1988) 414.
70. Krishna R, McIntosh N, Riggs K W & Mayer L D, Doxorubicin encapsulated in sterically stabilized liposomes exhibits renal and biliary clearance properties that are independent of valspodar (PSC 833) under conditions that significantly inhibit nonencapsulated drug excretion, Clinical Cancer Research, 5 (1999) 2939.
71. Phillips W T, Klipper R & Goins B, Novel method of greatly enhanced delivery of liposomes to lymph nodes, J Pharmacol Exp Therap, 295 (2000) 309.
72. Ceruti M, Crosasso P, Brusa P, Arpicco S, Dosio F & Cattel L, Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel, J Controlled Release, 63 (2000) 141.
73. Ohtake S, Schebor C, Palecek S P & De Pablo J J, Effect of sugar-phosphate mixtures on the stability of DPPC membranes in dehydrated systems, Cryobiology, 48 (2004) 81.
74. Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Mamoru S Y & Oku N, Oral delivery of insulin by using surface coating liposomes Improvement of stability of insulin in GI tract, Int J Pharmaceutics, 157 (1997) 73.
75. Martin C, Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y & Alpar H O, Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery, Int J Pharmaceutics, 298 (2005) 339.
76. Lidgate D M, Felgner P L, Fleitman J S, Whatley J, Fu R C, In vitro and in vivo studies evaluating a liposome system for drug solubilization, Pharm Res, 5 (1988) 759.
77. Campbell R B, Balasubramanian S V & Straubinger R M, Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties, Biochimica et Biophysica Acta, 1512 (2001) 27.
78. Kunisawa J, Nakagawa S & Mayumi T, Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development, Advanced Drug Delivery Reviews, 52 (2001) 177.
79. Foldvari M J, Effect of vehicle on topical liposomal drug delivery: petrolatum bases, J Microencapsul, 13 (1996) 589.
80. Jayesh R Bellare & Kapil Daga, Liposome mediated gene delivery, Drug Delivery Technology, 5 (2005).
81. Feril Jr L B, Ogawa R, Kobayashi H, Kikuchi H & Kondo T, Ultrasound enhances liposome-mediated gene transfection, Ultrasonics Sonochemistry, 12 (2005) 489.
82. Brazeau G A, Attia S, Poxon S & Hughes J A, In vitro myotoxicity of selected Cationic Macromolecules used in Non-viral Gene Delivery, Pharmaceutical Res, 15 (1998) 680.
83. Kirby A J, Camilleri P, Engberts J B F N, Feiters M C, Nolte R J M, Sderman O, Bergsma M, Bell P C, Fielden M L, Rodriguez C L G, Gudat P, Kremer A, McGregor C, Perrin C, Ronsin G & VanEijk M C P, Gemini Surfactants: New Synthetic Vectors for Gene Transfection, Angew Chem Int Ed, 42 (2003) 1448.
84. Morilla M J, Montanari J, Frank F, Malchiodi E, Corral R, Petray P & Romero E L, Etanidazole in pH-sensitive liposomes: Design, characterization and in vitro/in vivo anti- Trypanosoma cruzi activity, J Controlled Release, 103 (2005) 599.
85. Chen D, Cole D L & Srivatsa S G, Determination of free and encapsulated oligonucleotides liposome formulated drug product, J Pharmaceut Biomed Analy, 22 (2000) 791.
86. Lee CM, Hyun-Chul Lee, & Ki-young Lee, OPalmitoylcurdlan Sulfate (Occurs)-Coated Liposomes for oral Drug Delivery, J Biosci Bioeng, 100 (2005) 255.
87. Sudimack J J, Guo W, Tjarks W, Lee R J, A novel pHsensitive liposome formulation containing oleyl alcohol, Biochim Biophys Acta, 1564 (2002) 31.
88. Shi G, Guo W, Stephenson S M & Lee R J, Efficient intracellular drug and gene delivery using folate receptortargeted pH-sensitive liposomes composed of cationic / anionic lipid combinations, J Controlled Release, 80 (2002) 309.
89. Giri J, Sanjukta G T, Jayesh R. Bellare, Nigam A K, and Bahadur D, Preparation and characterization of phospholipids stabilized uniform sized magnetite nanoparticles, J Magnetism Magnetic Materials, 2931 (2005) 62-68.
90. Elmi M M & Sarbolouki M N, A simple method for preparation of immuno-magneticliposomes, Inter J Pharmaceutics, 215 (2001)45.
91. Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y & Murakami T, Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters, Int J Onco, 18 (2001)121.
92. Jain S, Mishra V, Singh P, Dubey P K, Saraf D K & Vyas S.P, RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting, Int J Pharmaceut, 261 (2003) 43.
93. Hallahan, DE Qu S, Geng L, Cmelak A, Chakravarthy A, Martin, William, Scarfone, C, & GiorgioT, Radiation- Mediated Control of Drug Delivery, Am J Clin Oncol, 24 (2001) 473.
94. Zhang J Q & Lu B, Studies on lung targeted niosomes of carboplatin, Acta Pharmaceutica sinica, 36 (2001) 303.
95. Ruckmani K, Jayakar B & Ghosal S K, Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release, Drug Dev Ind Pharm, 26 (2000) 2217.
96. Shahiwala A & Misra A, Studies in topical application of niosomally entrapped Nimesulide, J Pharma Phramaceut Sci, 5 (2002) 220.
97. Manconi M, Sinico C, Valenti D, Loy G & Fadda A M, Niosomes as carriers for tretinoin. I. Preparation and properties, Int J Pharmaceutics, 234 (2002) 237.
98. Swapna M, Sibabrata. M & Kumar Basu M, Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent in both liposomal and niosomal forms, J Antimicrob Chemother, 44 (1999) 791.
99. Saikat Das, Banerjee R, & Jayesh R Bellare, Aspirin loaded albumin nanoparticles by coacervation: implications in drugdelivery, Med India Trends in Biomaterials and Artificial Organs, 18 (2005).
100. Murdan S, Gregoriadis G & Florence A T, Sorbitan monoostearate / polysorbate 20 organogels containing niosomes: A delivery vehicle for antigens, Eur J Pharmaceut Sci, 8 (1999) 177.
101. Uchegbu I F &Duncan R, Niosomes containing N-(2- hydroxypropyl) methacrylamide copolymer-doxorubicin (PK1): effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution, Int J Pharmaceutics, 155 (1997) 7.
102. Luan L B, Zhu J B, Yu W P, Wei K B, Studies on the preparation of camptothecin niosomes, Yao Xue Xue Bao, 37(2002) 59.
103. Uchegbu I, The biodistribution of novel 200-nm palmitoyl muramic acid vesicles, Int J Pharmaceutics, 162 (1998) 19.
104. Jia-You Fang, Chi-Tzong, Wen-Ta Chiu & Wang Y Y, Effect of Liposomes and niosomes on skin permeation of enoxacin, Int J Pharmaceutics, 219 (2001) 61.
105. Hao Y, Zhao F, Li N, Yang Y & Kean Li, Studies on a high encapsulation of colchicine by a niosome system, Int J Pharmaceutics, 244 (2002) 73.
106. Agarwal R, Katare O P &Vyas S P, Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol, Int J Pharmaceutics, 228 (2001) 43.
107. Valenta C, Wanka M & Heidlas J, Evaluation of novel Soyalecithin formulations for dermal use containing ketoprofen as a model drug, J Controlled Release, 63 (2000) 165.
108. Rentel C O, Bouwstra J A, Naisbett B, Junginger H E, Niosomes as a novel peroral vaccine delivery system, Int J Pharmaceutics, 186 (1999) 161.
109. Bhavana V, Khopade A J & Jain N K, Proniosomes based transdermal delivery of levonorgestrel for effective contraception, J Controlled Release, 54 (1998)149.
110. Blazek-Welsh A I & Rhodes D G, Maltodextrin-based Proniosomes, AAPS Pharmsci, 3 (2000) 1.
111. Alsarra I A, Bosela A A, Ahmed S M, Mahrous G M, Proniosomes as a drug carrier for transdermal delivery of ketorolac, Eur J Pharmaceutics& Biopharmaceutics, 59 (2005) 485.
112. Jia-You F, Song-Yih Yu, Pao-Chu Wu, Yaw-Bin Huang, & Sai Y T, In vitro skin permeation of estradiol from various proniosome formulations, Int J Pharmaceutics, 215 (2001) 91.
113. Chengjiu Hu & Rhodes D G, Proniosomes: A Novel Drug carrier Preparation, Int J Pharmaceutics, 185 (1999) 23.
114. Uchegbu I F & Florence A T, Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry, Advance Colloid Interface Sci. 58 (1995)1.
115. Uchegbu I F, McCarthy D, Schatzlein A, Florence AT, Phase transitions in aqueous dispersions of the hexadecyl diglycerol ether (C16G2) non-ionic surfactant, cholesterol and cholesterol poly-24-oxyethylene ether: vesicles, tubules, discomes and micelles, S.T.P. Pharma Sci, 6 (1996) 33.
116. Arunothayanun P, Uchegbu I F, Craig D Q M, Turton J A & Florence A T, In vitro: in vivo characterization of polyhedral niosomes, Int J Pharmaceutics, 183 (1999) 57.
117. Lara M G, Bentley M V L B & Collett J H, In vitro drug release mechanism and drug loading studies of cubic phase gels, Int J Pharmaceutics, 293 (2005) 241.
118. Chin-Ming C & Bodmeier R, Effect of dissolution media and additives on the drug release from cubic phase delivery systems, J Controlled Release, 46 (1997) 215.
119. Bojrup M, Zhongquan Qi, Bjorkman S, Ostraat O, Landin B, Ljusberg-Wahren H & Ekberg H, Bioavailability of cyclosporine in rats after intragastric administration: a comparative study of the L2 phase and two other lipid phase, Transplant Immunology, 4 (1996) 313.
120. Lee J & Kellaway I W, In vitro peptide release from liquid crystalline buccal delivery systems, Int J Pharmaceutics, 195 (2000) 29.
121. Brinon L, Geiger S, Alard, Doucette J, Jean-Francois T & Couarraze G, Percutaneous absorption of sunscreens from liquid crystalline phases, J Controlled Release, 60 (1999) 67.
122. Makai M, Erzsebet C, Imre D, Nemeth Z & Eros I, Structural properties of nonionic surfactant/glycérol/paraffin lyotropic liquid crystals, Colloid Polym Sci, 281 (2003) 839.
123. Moghimi H R, Williams A C & and Barry B W, A lamellar matrix model for stratum corenum intercellular lipids I. Characterization and comparison with stratum corneum intercellular structure, Int J Pharmaceutics, 125 (1995) 231.
124. Kriwet K, & Miiller-Goymann C C, Diclofenac release from phospholipids drug systems and permeation through excised human stratum corneum, Int J Pharmaceutics, 125 (1995) 231.
125. Technov B, Rappolt M, Koynova R & Gret Rapp, New phases induced by sucrose in saturated phosphatidylethanolamines:an expanded lamellar gel phase and a cubic phase, Biochimica et Biophysica acta, 1285 (1996) 109.
126. Farkas E, Zelkoa R, Nemeth Z S, Palinka J, Marton S &. Racz I, The effect of liquid crystalline structure on chlorhexidine diacetate release, Int J Pharmaceutics, 193 (2000) 239.
127. Comelles F, Sanchez-Leal J & Gonza lez J J, Lamellar liquid crystals made of anionic surfactant, oleic acid, diethyleneglycol monoethyl ether and water, Colloid Polym Sci, 283 (2005) 925.
128. Koltover I, Salditt T, Radler J O & Sanya C R, An Inverted Hexagonal Phase of Cationic liposome DNA complexes related to DNA release and delivery, Science, 281 (1998) 78.
129. Bruno P, Aguerre O, Airiau M, Anne-Marie L, Boukhnikachvili T, Gerardo Byk, Dubertret C, Herviou C, Scherman D, Jean -Francois M & Crouzet J, Virus-sized selfassembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer, Proc Natl Acad Sci USA, 94 (1997) 14412.
130. Al-Sayed S, Khalil E, Ibrahim H & Freij F, Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glycerol monooleate, Eur J Pharmaceutics Biopharmaceutics, 53 (2002) 343.
131. Labat M F. Steffan A M, Brisson C, Perron H, Feugas O, Furstenberge R P, Oberling F, Brambilla E & Behr J P, An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther, 3 (1996) 1010.
132. Barauskas J, Johnsson M, & Tiberg F, Self-Assembled Lipid Superstructures: Beyond Vesicles and Liposomes, Nanoletters, 5 (2005) 1615.
133. Clogston J, Craciun G, Hart D J & Caffrey M, Controlling release from the lipidic cubic phase by selective alkylation, J Controlled Release, 102 (2005) 441.
134. Clogston J & Caffrey M, Controlling release from the lipidic cubic phase Amino acids, peptides, proteins and nucleic acids, J Controlled Release, 107 (2005) 97.
135. Spicer P T, Small W B, Lynch M L & Burns J.L, Dry Powder Preursors of soft cubic liquid crystalline Nanoparticles (Cubosomes), J Nanoparticle Res, 4 (2002a) 297.
136. Pereria G R, Collett J H, Garacia S B, Thomani J A & Bentley M V L B, Glycerol monooleate/solvents systems for progesterone transdermal delivery : In vitro permeation and microscopic studies, Brazilian J Pharmaceutical Sci, 38 (2002) 55.
137. Helledi L S & Schubert L, Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system, Drug Develop Indust Pharmacy, 27 (2001) 1073.
138. Chin-Ming C & Bodmeier R, Binding of drugs to monoglyceride-based drug delivery systems, International J Pharmaceutics, 147 (1997) 135.
139. Geraghty P B, Attwood D, Collett J H & Dandiker Y, The in vitro release of some antimuscarinic drug from monoolein/water lyotropic liquid crystalline gels, Pharmaceutical Res, 13 (1996) 1265.
140. Chin-Ming C and Bodmeier R, Low viscosity monoglyceride -based drug delivery systems transforming into a highly viscous cubic phase, Int J Pharmaceutics, 173 (1998) 51.
141. Lopes L B, Collett J H & Bentley M V L B, Glycerol monooleate /solvents systems for progesterone transdermal delivery: In vitro permeation and microscopic studies, Eur J Pharmaceutics Biopharmaceutics, 60 (2005) 25.
142. Engstrom S, Norden T P & Nyquist H, Cubic phases for studies of drug partition into lipid bilayers, Eur J Pharmaceutical Sci, 8 (1999) 243.
143. Lynch M L, Ofori-Boateng A, Hippe A, Kochvar K & Spicer P T, Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants, J Colloid Interface Sci, 260 (2003) 404.
144. Dubois M, Deme B, Gulik-Krzywicki T, Jean-Claude D, Vautrin C, Desert S, Perez E & Zemb T, Self-assembly of regular hollow icosahedra in salt-free catanionic solutions, Nature, 411 (2001) 672.
145. Zemb T, Dubois M, Deme B & Gulik-Krzywicki T, Selfassembly of flat nanodiscs in salt-free catanionic surfactant solutions, Science, 283 (1999) 816.
146. Hyde S T, Topological transformations mediated by bilayer punctures: from sponge phases to bicontinuous monolayer and reversed sponges, Colloids Surf A, 129-130 (1997) 207.
147. Jeffrey L. T, Zhiyun C & Karen L W, Regiochemical functionalization of a nanoscale cage-like structure: Robust core-shell nanostructures crafted as vessels for selective uptake and release of small and large guests, J Controlled Release, 109 (2005) 189.
148. Alex S G, Lukyanov A N, Paul A C, Yager P & Gelb M H, Formation of high-axial-ratio-microstructures from natural and synthetic sphingolipids, Chem Phy Lipids, 88 (1997) 21.
149. Alex S G, Gelb M H & Yager P, The relationship between the structure of the head group of sphingolipids and their ability to form complex high axial ratio microstructures, Chem Phy Lipids, 109 (2001) 1.
150. Lee K C, Lukyanov A N, Gelb M H & Yager P, Formation of high axial ratio microstructures from peptides modifiedwith glutamic acid dialkyl amides, Biochimica et Biophysica Acta, 1371 (1998) 168.
151. Liao I, -C, Andrew C A Wan, Evelyn K F Yim & Leong K MY, Controlled release from fibers of polyelectroyte complexes, J Controlled Release, 104 (2005) 347.
152. Mooney D J, Mazzoni C L, Breued C, McNamara K. H, Vacanti J P& Langer R, Stabilized polyglycolic acid fiber based tubes for tissue engineering, Biomaterials, 17 (1996) 115.
153. Choi S & Kim S W, Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats, Pharmaceutical Research, 20 (2003) 2008.
154. Rosaria S, Padma P, Guillaume D, Zi-Wei Chen, Mannino R, Zarif L & David S.P, Efficacy of oral Cochleate- Amphotericin B in a mouse model of systemic Candidasis, Antimicrobial and Chemotherapy, 44 (2000) 2356.
155. Zarif L, John R G, David S P, Laura N, Bocanegra R & Mannino R, Antifungal Activity of Amphotericin B Cochleates against Candida albicans Infection in a mouse model, Antimicrobial and Chemotherapy, 44 (2000) 1463.
156. Zarif L, Graybill Jr, Perlin D & Mannino R J, Cochleates new lipid based drug delivery system, J Liposome Res, 10 (2000) 523.
157. Gould-Fogerite S, Kheiri M T, Zhang F, Wang Z, Scolpine A J, Feketeova E, Canki M &Mannino R J, Targeting immune response induction with cochleate and liposome -based vaccines, Advanced Drug Delivery Reviews, 32 (1998) 273.
158. Janoff A S, Boni L T, Popescu M C, Minchey S R, Cullis P R, Madden T D, Taraschi T, Grunder S M, Shyamsunder E, Tae M W, Mendelsohn R & Bonner D, Unusual lipid structures selectively reduces the toxicity of amphotericin B, Proc Natl Acad Sci USA, 85 (1988) 6122.
159. Janoff A S, Perkins W R, Saletan S L & Swenson C E, Amphotericin B lipid complex (ABLCE) a molecular rationale for the attenuation of amphotericin B related toxicity, J Liposome Res, 3 (1993) 451.
160. Cara C Evans & Joseph Zasadzinski, Encapsulating vesicles and colloids from cochleate cylinders, Langmuir, 19 (2003) 3109.
161. Sakurai I, Shibata I, Minobe M & Kawamura Y, Free vertical growth of myelin figures, Mol Cryst Liq Cryst. 363 (2001) 157.
162. Arunagirinathan M A, Roy M D, A K, Manohar C & Jayesh. R. Bellare, Micro-Raman investigations of myelins in aerosol-OT/water system, Langmuir, 20 (2004) 4816.
163. Arunagirinathan M A, Manohar C & Jayesh. R. Bellare, Eroded myelin figures, Langmuir, 20 (2004) 4318.
164. Buchnan M, Arrault J & Cates M E, Swelling and dissolution of lamellar phases: Role of bilayer organization, Langmuir, 14 (1998) 7371.